Taking their cue from the druggable genome, a group of researchers have scoured publicly available…
Life Science and Healthcare
Open goals: will AlphaFold2’s ‘open science’ usher in a drug discovery revolution?
DeepMind has handed researchers the tools to implement AlphaFold2 and explore its ground-breaking potential for…
‘We are just starting to see the full spectrum of data science applications in agriculture’
With climate change and a growing world population to contend with, the agriculture industry is…
BioBERT: the new NLP model giving drug development teams a boost
With more than a million biomedical research papers published each year, no human researcher can…
Into the unknown: the quest to target the ‘undruggable’ proteome
A staggering 85% of the human proteome has been deemed ‘undruggable’. But, spurred on by…
BANDIT: using diverse data to measure drug similarity and predict drug targets
Similar small molecules tend to be similarly effective against disease, often sharing the same target.…
Taking out the trash: how protein degraders could help us fight disease
Of the 75%+ of human proteins not currently targetable by drugs, some are known cancer…
Sci-fi or AI? What will a supercharged pharmaceutical industry look like?
Fully digitised, AI-directed, in-silico drug discovery and development programs are not just a pipe dream…
Correcting confounding biases in genome-wide association studies
Linkage disequilibrium score regression is already being put to good use in drug discovery, by…
Double strength: how can we better predict effective, as-yet untried, drug combinations?
Some things just work better with two – but when it comes to drug combinations,…